These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36126606)

  • 21. Triclosan and its derivatives as antimycobacterial active agents.
    Vosátka R; Krátký M; Vinšová J
    Eur J Pharm Sci; 2018 Mar; 114():318-331. PubMed ID: 29277667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Advances and Structural Features of Enoyl-ACP Reductase Inhibitors of Mycobacterium tuberculosis.
    Inturi B; Pujar GV; Purohit MN
    Arch Pharm (Weinheim); 2016 Nov; 349(11):817-826. PubMed ID: 27775177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis.
    Sullivan TJ; Truglio JJ; Boyne ME; Novichenok P; Zhang X; Stratton CF; Li HJ; Kaur T; Amin A; Johnson F; Slayden RA; Kisker C; Tonge PJ
    ACS Chem Biol; 2006 Feb; 1(1):43-53. PubMed ID: 17163639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The first-in-class pyrazole-based dual InhA-VEGFR inhibitors towards integrated antitubercular host-directed therapy.
    Shaaban MM; Teleb M; Ragab HM; Singh M; Elwakil BH; A Heikal L; Sriram D; Mahran MA
    Bioorg Chem; 2024 Apr; 145():107179. PubMed ID: 38367430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of novel N-methyl carbazole tethered rhodanine derivatives as direct inhibitors of Mycobacterium tuberculosis InhA.
    Shaikh MS; Kanhed AM; Chandrasekaran B; Palkar MB; Agrawal N; Lherbet C; Hampannavar GA; Karpoormath R
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2338-2344. PubMed ID: 31227345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Hybrid 1,2,4- and 1,2,3-Triazoles Targeting Mycobacterium Tuberculosis Enoyl Acyl Carrier Protein Reductase (InhA): Design, Synthesis, and Molecular Docking.
    El Sawy MA; Elshatanofy MM; El Kilany Y; Kandeel K; Elwakil BH; Hagar M; Aouad MR; Albelwi FF; Rezki N; Jaremko M; El Ashry ESH
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-Benzyl-4-((heteroaryl)methyl)benzamides: A New Class of Direct NADH-Dependent 2-trans Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity.
    Guardia A; Gulten G; Fernandez R; Gómez J; Wang F; Convery M; Blanco D; Martínez M; Pérez-Herrán E; Alonso M; Ortega F; Rullás J; Calvo D; Mata L; Young R; Sacchettini JC; Mendoza-Losana A; Remuiñán M; Ballell Pages L; Castro-Pichel J
    ChemMedChem; 2016 Apr; 11(7):687-701. PubMed ID: 26934341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, in vitro and in silico evaluation of novel substituted 1,2,4-triazole analogues as dual human VEGFR-2 and TB-InhA inhibitors.
    Zawal AG; Abdel-Aziz MM; Elbatreek MH; El-Shanawani AA; Abdel-Aziz LM; Elbaramawi SS
    Bioorg Chem; 2023 Dec; 141():106883. PubMed ID: 37774433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triclosan derivatives: towards potent inhibitors of drug-sensitive and drug-resistant Mycobacterium tuberculosis.
    Freundlich JS; Wang F; Vilchèze C; Gulten G; Langley R; Schiehser GA; Jacobus DP; Jacobs WR; Sacchettini JC
    ChemMedChem; 2009 Feb; 4(2):241-8. PubMed ID: 19130456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agents.
    Tiwari AP; Sridhar B; Boshoff HI; Arora K; Gautham Shenoy G; Vandana KE; Varadaraj Bhat G
    Mol Divers; 2020 Nov; 24(4):1265-1279. PubMed ID: 31506871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis.
    Pedgaonkar GS; Sridevi JP; Jeankumar VU; Saxena S; Devi PB; Renuka J; Yogeeswari P; Sriram D
    Eur J Med Chem; 2014 Oct; 86():613-27. PubMed ID: 25218910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virtually Designed Triclosan-Based Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis and of Plasmodium falciparum.
    Owono Owono LC; Ntie-Kang F; Keita M; Megnassan E; Frecer V; Miertus S
    Mol Inform; 2015 May; 34(5):292-307. PubMed ID: 27490275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of 2-(2-isonicotinoylhydrazineylidene)propanamides as InhA inhibitors with high antitubercular activity.
    Pflégr V; Horváth L; Stolaříková J; Pál A; Korduláková J; Bősze S; Vinšová J; Krátký M
    Eur J Med Chem; 2021 Nov; 223():113668. PubMed ID: 34198149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent progress in the identification and development of InhA direct inhibitors of Mycobacterium tuberculosis.
    Lu XY; You QD; Chen YD
    Mini Rev Med Chem; 2010 Mar; 10(3):181-92. PubMed ID: 20408801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid.
    Parikh SL; Xiao G; Tonge PJ
    Biochemistry; 2000 Jul; 39(26):7645-50. PubMed ID: 10869170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel peptidomimetic peptide deformylase (PDF) inhibitors of Mycobacterium tuberculosis.
    Gokhale KM; Telvekar VN
    Chem Biol Drug Des; 2021 Jan; 97(1):148-156. PubMed ID: 32745362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Machine learning assisted methods for the identification of low toxicity inhibitors of Enoyl-Acyl Carrier Protein Reductase (InhA).
    Chikhale RV; Abdelghani HTM; Deka H; Pawar AD; Patil PC; Bhowmick S
    Comput Biol Chem; 2024 Jun; 110():108034. PubMed ID: 38430612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the plasticity of the InhA substrate-binding site using new diaryl ether inhibitors.
    Tamhaev R; Grosjean E; Ahamed H; Chebaiki M; Rodriguez F; Recchia D; Degiacomi G; Pasca MR; Maveyraud L; Mourey L; Lherbet C
    Bioorg Chem; 2024 Feb; 143():107032. PubMed ID: 38128204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis.
    Matviiuk T; Madacki J; Mori G; Orena BS; Menendez C; Kysil A; André-Barrès C; Rodriguez F; Korduláková J; Mallet-Ladeira S; Voitenko Z; Pasca MR; Lherbet C; Baltas M
    Eur J Med Chem; 2016 Nov; 123():462-475. PubMed ID: 27490025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time-dependent diaryl ether inhibitors of InhA: structure-activity relationship studies of enzyme inhibition, antibacterial activity, and in vivo efficacy.
    Pan P; Knudson SE; Bommineni GR; Li HJ; Lai CT; Liu N; Garcia-Diaz M; Simmerling C; Patil SS; Slayden RA; Tonge PJ
    ChemMedChem; 2014 Apr; 9(4):776-91. PubMed ID: 24616444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.